Cargando…

Haematological and nutritional prognostic biomarkers for patients receiving CROSS or FLOT

BACKGROUND: Neoadjuvant carboplatin and paclitaxel with radiotherapy (CROSS) and perioperative docetaxel, oxaliplatin, calcium folinate and fluorouracil (FLOT) are widely used for gastric (GC), gastro-oesophageal junction (GOJ) and oesophageal cancers (OC). Prognostic and predictive markers for resp...

Descripción completa

Detalles Bibliográficos
Autores principales:	McNamee, Nicholas, Nindra, Udit, Shahnam, Adel, Yoon, Robert, Asghari, Ray, Ng, Weng, Karikios, Deme, Wong, Mark
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186526/ https://www.ncbi.nlm.nih.gov/pubmed/37201072 http://dx.doi.org/10.21037/jgo-22-886

Ejemplares similares

Real-World Outcomes of FLOT versus CROSS Regimens for Patients with Oesophagogastric Cancers
por: Shahnam, Adel, et al.
Publicado: (2023)

Se maintenir à flot
por: Auer, Rebecca Ann C.
Publicado: (2021)

Elevated neutrophil‐to‐lymphocyte ratio (NLR) is associated with poorer progression‐free survival in unresectable stage III NSCLC treated with consolidation durvalumab
por: Nindra, Udit, et al.
Publicado: (2022)

Un flot ininterrompu de données
por: Ourghanlian, Bernard
Publicado: (2006)

Results of the observational prospective RealFLOT study
por: Giommoni, Elisa, et al.
Publicado: (2021)

The roles of FLOT1 in human diseases (Review)
por: Zhan, Ziqing, et al.
Publicado: (2023)

Preventive HIPEC in combination with perioperative FLOT versus FLOT alone for resectable diffuse type gastric and gastroesophageal junction type II/III adenocarcinoma – the phase III “PREVENT”- (FLOT9) trial of the AIO /CAOGI /ACO
por: Götze, Thorsten O., et al.
Publicado: (2021)

Changes in selected metabolic parameters in patients over 65 receiving hydrochlorothiazide plus amiloride, atenolol or placebo in the MRC elderly trial
por: Damian, Damian J., et al.
Publicado: (2016)

Delayed Posterior Reversible Leukoencephalopathy Syndrome Triggered by FLOT Chemotherapy
por: Gandini, Jordi, et al.
Publicado: (2020)

Concurrent Paraneoplastic Dermatomyositis and Acquired C1 Esterase Inhibitor Deficiency in Primary Laryngeal Small Cell Carcinoma
por: Nindra, Udit, et al.
Publicado: (2021)

Exploring the impact and experience of fractional work in medicine: a qualitative study of medical oncologists in Australia
por: Kirby, Emma, et al.
Publicado: (2019)

Identification of Novel Raft Marker Protein, FlotP in Bacillus anthracis
por: Somani, Vikas K., et al.
Publicado: (2016)

FLOT2 overexpression is associated with the progression and prognosis of human colorectal cancer
por: Li, Taiyuan, et al.
Publicado: (2019)

Dynamics and Endocytosis of Flot1 in Arabidopsis Require CPI1 Function
por: Cao, Yangyang, et al.
Publicado: (2020)

Expenditure and Nutritional Impact of Banning the Promotion of Foods High in Fat, Sugar and Salt in Scotland
por: Revoredo-Giha, Cesar, et al.
Publicado: (2022)

Multigene panel next generation sequencing in metastatic colorectal cancer in an Australian population
por: Nindra, Udit, et al.
Publicado: (2023)

Pretreatment Modified Glasgow Prognostic Score for Predicting Prognosis and Survival in Elderly Patients with Gastric Cancer Treated with Perioperative FLOT
por: Melekoglu, Ebru, et al.
Publicado: (2023)

A systematic review of neoadjuvant and definitive immunotherapy in locally advanced head and neck squamous cell carcinoma
por: Nindra, Udit, et al.
Publicado: (2023)

Discussion of costs and financial burden in clinical practice: A survey of medical oncologists in Australia
por: Agarwal, Anupriya, et al.
Publicado: (2022)

High Expression of FLOT1 Is Associated with Progression and Poor Prognosis in Hepatocellular Carcinoma
por: Zhang, Shi-Hong, et al.
Publicado: (2013)

An Analysis of Tolerance and Early Survival Outcomes with Perioperative Modified FLOT in Gastric Cancers
por: Bhargava, Prabhat, et al.
Publicado: (2022)

General practitioner knowledge, skills and attitudes to eating disorders
por: Doherty, S, et al.
Publicado: (2015)

Gene Transfer for Pain: A tool to cope with the intractable, or an unethical enduranceenhancing technology?
por: Camporesi, S, et al.
Publicado: (2012)

Prognostic factors of perioperative FLOT regimen in operable gastric and gastroesophageal junction tumors: real-life data (Turkish Oncology Group)
por: EROL, Cihan, et al.
Publicado: (2022)

Nutritional supplement use by elite young UK athletes: fallacies of advice regarding efficacy
por: Petróczi, Andrea, et al.
Publicado: (2008)

A Qualitative Study of Medical Oncologists’ Experiences of Their Profession and Workforce Sustainability
por: Broom, Alex, et al.
Publicado: (2016)

A Rare Case of Castrate-Resistant Prostate Adenocarcinoma with a Unilateral Testicular Metastasis Mimicking a Primary Testicular Tumour
por: Hong, Jun Hee, et al.
Publicado: (2022)

Discussing and prescribing expensive unfunded anticancer drugs in Australia
por: Karikios, Deme John, et al.
Publicado: (2017)

Translational Science by Public Biotechnology Companies in the IPO“Class of 2000”: The Impact of Technological Maturity
por: McNamee, Laura, et al.
Publicado: (2013)

Introduction
por: McNamee, Terence, et al.
Publicado: (2020)

Flot2 acts as a novel mediator of podocyte injury in proteinuric kidney disease
por: Yu, Chunping, et al.
Publicado: (2023)

Retrospective comparison of flot and modified dcf as first-line chemotherapy in metastatic gastric adenocarcinoma
por: GÜRLER, Fatih, et al.
Publicado: (2022)

Interactions between Australian cancer physicians and the pharmaceutical industry: a qualitative study
por: Pokorny, Adrian M J, et al.
Publicado: (2023)

Performance enhancement, elite athletes and anti doping governance: comparing human guinea pigs in pharmaceutical research and professional sports
por: Camporesi, Silvia, et al.
Publicado: (2014)

Consent, ethics and genetic biobanks: the case of the Athlome project
por: Thompson, Rachel, et al.
Publicado: (2017)

Interaction of different lipoprotein types with cholesterol at the air/water interface
por: Ninomiya, Ryota, et al.
Publicado: (2020)

Perioperative FLOT chemotherapy plus surgery for oligometastatic esophagogastric adenocarcinoma: surgical outcome and overall survival
por: Runkel, Mira, et al.
Publicado: (2021)

The scaffolding protein flot2 promotes cytoneme-based transport of wnt3 in gastric cancer
por: Routledge, Daniel, et al.
Publicado: (2022)

Impact of neoadjuvant FLOT treatment of advanced gastric and gastroesophageal junction cancer following surgical therapy
por: Paszt, Attila, et al.
Publicado: (2023)

FLOT1 promotes gastric cancer progression and metastasis through BCAR1/ERK signaling
por: Wang, Ran, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qtn65uibjgpqorrd5mq4l2j7sd